title: Re: Disease Control Outcomes from Analysis of Pooled Individual Patient Data from Five Comparative Randomized Clinical Trials of Degarelix Versus Luteinising Hormone-releasing Hormone Agonists.
authors.affiliation: Department of Urology, University Hospital of Poitiers, Poitiers, France. Electronic address: j.irani@chu-poitiers.fr.
authors.forename: Jacques
authors.initials: J
authors.lastname: Irani
mesh_terms: D018931:Antineoplastic Agents, Hormonal / Q000627:therapeutic use*; D007987:Gonadotropin-Releasing Hormone / Q000819:agonists*; D017273:Goserelin / Q000627:therapeutic use*; D006801:Humans; D016729:Leuprolide / Q000627:therapeutic use*; D008297:Male; D009842:Oligopeptides / Q000627:therapeutic use*; D011471:Prostatic Neoplasms / Q000188:drug therapy*
chemical_list: D018931:Antineoplastic Agents, Hormonal; D009842:Oligopeptides; D017273:Goserelin; D007987:Gonadotropin-Releasing Hormone; D016729:Leuprolide